81
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years

, MD, , MSc, , BSc, , MD, , MD, , MD, , MD, , MD, , MScORCID Icon, , MD, , BSc, , BSc, , BSc, PhD, , BSc, PhD, , MD, PhD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, PhD, , MD, , MD, , MD, , MD & , MD show all
Received 21 Jul 2023, Accepted 13 Dec 2023, Published online: 10 Jan 2024

References

  • Bloch-Michel E, Nussenblatt R. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103(2):234–235. doi:10.1016/S0002-9394(14)74235-7.
  • Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23(5):705–717. doi:10.5301/ejo.5000278.
  • Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:10.1080/09273948.2016.1196713.
  • de Smet MD, Taylor SRJ, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011;30(6):452–470. doi:10.1016/j.preteyeres.2011.06.005.
  • Castelli F, Sulis G. Migration and infectious diseases. Clin Microbiol Infect. 2017;23(5):283–289. doi:10.1016/j.cmi.2017.03.012.
  • Cimino L, Aldigeri R, Salvarani C, et al. The causes of uveitis in a referral centre of Northern Italy. Int Ophthalmol. 2010;30(5):521–529. doi:10.1007/s10792-010-9359-y.
  • Cimino L, Aldigeri R, Marchi S, et al. Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases. Int Ophthalmol. 2018;38(1):133–142. doi:10.1007/s10792-017-0466-x.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, Group. S of UN (SUN) W. Standardization of uveitis nomenclature for reporting clinical data. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.Standardization.
  • Gozzi F, Belloni L, Aldigeri R, et al. Aqueous humor analysis in overlapping clinical diagnosis of cytomegalovirus and rubella virus anterior uveitis. Medicine. 2022;58(8):1–10. doi:10.3390/medicina58081054.
  • De Simone L, Belloni L, Aldigeri R, et al. Aqueous tap and rapid diagnosis of cytomegalovirus anterior uveitis: the Reggio Emilia experience. Graefe’s Arch Clin Exp Ophthalmol. 2019;257(1):181–186. doi:10.1007/s00417-018-4180-9.
  • Holland G. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive committee of the American uveitis society. Am J Ophthalmol. 1994;117(5):663–667. doi:10.1016/S0002-9394(14)70075-3.
  • Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10):1418–1422. doi:10.1136/bjophthalmol-2018-313356.
  • Abu El-Asrar AM, Abouammoh M, Al-Mezaine HS. Tuberculous Uveitis. Int Ophthalmol Clin. 2006;50(2):19–39. doi:10.1097/IIO.0b013e3181d2ccb9.
  • International Study Group for Behcet’s disease. Criteria for diagnosis of Behcet’s disease. Lancet. 1990;335(8697):1078–1080. doi:10.1016/0140-6736(90)92643-V.
  • Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50(4):364–388. doi:10.1016/j.survophthal.2005.04.003.
  • European glaucoma society terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol. 2021;105(Suppl 1):1–169. doi:10.1136/bjophthalmol-2021-egsguidelines.
  • Mercanti A, Parolini B, Bonora A, Lequaglie Q, Tomazzoli L. Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmologica Scandinavica. 2001;79(1):64–68. doi:10.1034/j.1600-0420.2001.079001064.x.
  • Pivetti-Pezzi P, Accorinti M, La Cava M, Colabelli Gisoldi R, Abdulaziz M. Endogenous uveitis: an analysis of 1,417 cases. Ophthalmologica. 1996;210(4):234–238. doi:10.1159/000310715.
  • McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol. 1996;121(1):35–46. doi:10.1016/S0002-9394(14)70532-X.
  • Gianfredi V, Moretti M, Gigli M, Fusco-Moffa I. Unplanned migration flow: the acceptance system response, Perugia. Acta Biomed. 2019;90(3):253–258. doi:10.23750/abm.v90i3.7343.
  • Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008;15(5):285–293. doi:10.1080/09286580802262821.
  • Jones NP. The Manchester Uveitis Clinic: the first 3000 patients, 2: uveitis manifestations, complications, medical and surgical management. Ocul Immunol Inflamm. 2015;23(2):127–134. doi:10.3109/09273948.2014.968671.
  • Al Dhibi HA, Al Shamsi HN, Al-Mahmood AM, et al. Patterns of uveitis in a tertiary care referral institute in Saudi Arabia. Ocul Immunol Inflamm. 2017;25(3):388–395. doi:10.3109/09273948.2015.1133836.
  • Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223–236. doi:10.1159/000078612.
  • Suttorp-Schulten MSA, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80(9):844–848. doi:10.1136/bjo.80.9.844.
  • Weiner A, BenEzra D. Clinical patterns and associated conditions in chronic uveitis. Am J Ophthalmol. 1991;112(2):151–158. doi:10.1016/S0002-9394(14)76694-2.
  • Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114(5):593–599. doi:10.1001/archopht.1996.01100130585016.
  • Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a German interdisciplinary uveitis center - analysis of 1916 patients. J Rheumatol. 2009;36(1):127–136. doi:10.3899/jrheum.080102.
  • Oruc S, Kaplan AD, Galen M, Kaplan HJ. Uveitis referral pattern in a midwest university eye center. Ocul Immunol Inflamm. 2003;11(4):287–298. doi:10.1076/ocii.11.4.287.18270.
  • Polanía D, Reyes-Guanes J, Rojas-Carabali W, et al. A new look into uveitis in Colombia: changes in distribution patterns and clinical characteristics over the last 25 years. Graefe’s Arch Clin Exp Ophthalmol. 2023;261(2):561–573. doi:10.1007/s00417-022-05796-2.
  • Khairallah M, Yahia SB, Ladjimi A, et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye. 2007;21(1):33–39. doi:10.1038/sj.eye.6702111.
  • Das D, Bhattacharjee H, Bhattacharyya PK, et al. Pattern of uveitis in North East India: a tertiary eye care center study. Indian J Ophthalmol. 2009;57(2):144–146. doi:10.4103/0301-4738.45506.
  • Chauhan K, Scaife S, Rosenbaum JT. Uveitis and health disparities: results from the national inpatient sample. Br J Ophthalmol. 2019;103(9):1301–1305. doi:10.1136/bjophthalmol-2018-312048.
  • Hwang DK, Chou YJ, Pu CY, Chou P. Epidemiology of uveitis among the Chinese population in Taiwan: a population-based study. Ophthalmology. 2012;119(11):2371–2376. doi:10.1016/j.ophtha.2012.05.026.
  • Jones NP. The Manchester Uveitis Clinic: the first 3000 patients–epidemiology and casemix. Ocul Immunol Inflamm. 2015;23(2):118–126. doi:10.3109/09273948.2013.855799.
  • Jabs DA. Epidemiology of uveitis. Ophthalmic Epidemiol. 2008;15(5):283–284. doi:10.1080/09286580802478724.
  • Chang J-M, Wakefield D. Uveitis: a global perspective John Hyun-Min Chang. Ocul Immunol Inflamm. 2003;10(4):263–279. doi:10.1076/ocii.10.4.263.15592.
  • Gao F, Zhao C, Cheng G, et al. Clinical patterns of uveitis in a tertiary center in North China. Ocul Immunol Inflamm. 2017;25(April):S1–S7. doi:10.3109/09273948.2016.1158279.
  • Nakahara H, Kaburaki T, Takamoto M, et al. Statistical analyses of endogenous uveitis patients (2007–2009) in central Tokyo area and comparison with previous studies (1963–2006). Ocul Immunol Inflamm. 2015;23(4):291–296. doi:10.3109/09273948.2014.920036.
  • Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11(4):277–286. doi:10.1076/ocii.11.4.277.18260.
  • Chen SC, Chuang CT, Chu MY, Sheu SJ. Patterns and etiologies of uveitis at a tertiary referral center in Taiwan. Ocul Immunol Inflamm. 2017;25(1):S31–S38. doi:10.1080/09273948.2016.1189577.
  • Llorenç V, Mesquida M, Sainz De La Maza M, et al. Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization. Acta Ophthalmol. 2015;93(6):561–567. doi:10.1111/aos.12675.
  • Wong A, McKelvie J, Slight C, Sims J. Land of the long white cloud: the spectrum of uveitis at a tertiary referral center in New Zealand. Ocul Immunol Inflamm. 2017;25(September):S115–S121. doi:10.1080/09273948.2016.1203957.
  • Zagora SL, Symes R, Yeung A, Yates W, Wakefield D, McCluskey PJ. Etiology and clinical features of ocular inflammatory diseases in a tertiary referral centre in Sydney, Australia. Ocul Immunol Inflamm. 2017;25(1):S107–S114. doi:10.1080/09273948.2016.1247871.
  • Kamoi K, Watanabe T, Uchimaru K, et al. Updates on HTLV-1 Uveitis. Viruses. 2022;14(4):1. doi:10.3390/v14040794.
  • Al Dhahri H, Al Rubaie K, Hemachandran S, et al. Patterns of uveitis in a university-based tertiary referral center in Riyadh, Saudi Arabia. Ocul Immunol Inflamm. 2015;23(4):311–319. doi:10.3109/09273948.2014.939197.
  • Abaño JM, Galvante PR, Siopongco P, Dans K, Lopez J. Review of epidemiology of uveitis in Asia: pattern of uveitis in a tertiary hospital in the Philippines. Ocul Immunol Inflamm. 2017;25(1):S75–S80. doi:10.1080/09273948.2017.1335755.
  • Rahman Z, Ahsan Z, Rahman NA, Dutta Majumder P. Pattern of uveitis in a referral hospital in Bangladesh. Ocul Immunol Inflamm. 2018;26(6):893–896. doi:10.1080/09273948.2017.1281424.
  • Rajan RS, Mohamed SO, Salowi MA, et al. Demography and clinical pattern of newly diagnosed uveitis patients in Malaysia. J Ophthalmic Inflamm Infect. 2022;12(1). doi:10.1186/s12348-022-00306-1.
  • Julian LK, Balfour G, Forgues RF, de Smet MD, Suburo A. Uveitis patterns and severity: an epidemiologic study from a tertiary care private referral center in Buenos Aires, Argentina. Ocul Immunol Inflamm. 2022;31(4):710–716. doi:10.1080/09273948.2022.2053546.
  • Liberman P, Gauro F, Berger O, Urzua CA. Causes of uveitis in a tertiary center in Chile: a cross-sectional retrospective review. Ocul Immunol Inflamm. 2015;23(4):339–345. doi:10.3109/09273948.2014.981548.
  • de-la-Torre A, López-Castillo CA, Rueda JC, Mantilla RD, Gómez-Marín JE, Anaya JM. Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia. Clin Exp Ophthalmol. 2009;37(5):458–466. doi:10.1111/j.1442-9071.2009.02082.x.
  • Gonzalez Fernandez D, Nascimento H, Nascimento C, Muccioli C, Belfort R. Uveitis in São Paulo, Brazil: 1053 new patients in 15 months. Ocul Immunol Inflamm. 2017;25(3):382–387. doi:10.3109/09273948.2015.1132741.
  • de Moraes HMV, de Almeida MS, de Carvalho KA, Biancardi AL, de Moraes Junior HV. Causes and characteristics of uveitis cases at a reference university hospital in Rio de Janeiro, Brazil. Arq Bras Oftalmol. 2022;85(3):255–262. doi:10.5935/0004-2749.20220040.
  • London NJS, Rathinam SR, Cunningham ET. The epidemiology of uveitis in developing countries. Int Ophthalmol Clin. 2010;50(2):1–17. doi:10.1097/IIO.0b013e3181d2cc6b.
  • Bodaghi B, Cassoux N, Wechsler B, et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine. 2001;80(4):263–270. doi:10.1097/00005792-200107000-00005.
  • Ronday MJ, Stilma JS, Barbe RF, a K, Rothova A. Blindness from uveitis in a hospital population in Sierra Leone. Br J Ophthalmol. 1994;78(9):690–693. doi:10.1136/bjo.78.9.690.
  • Al-Shakarchi FI. Pattern of uveitis at a referral center in Iraq. Middle East Afr J Ophthalmol. 2014;21(4):291–295. doi:10.4103/0974-9233.142263.
  • Bagheri M, Ahoor MH, Jafari A, Hashem HS, Mohammadkhani M. Pattern of uveitis in Iran: a systematic review. J Ophthalmic Vis Res. 2021;16(1):93–102. doi:10.18502/jovr.v16i1.8255.
  • Al-Baker ZM, Bodaghi B, Khan SA. Clinical patterns and causes of uveitis in a referral eye clinic in Qatar. Ocul Immunol Inflamm. 2018;26(2):249–258. doi:10.1080/09273948.2016.1206573.
  • Jones NP, Pockar S, Steeples LR. Changing trends in uveitis in the United Kingdom: 5000 consecutive referrals to a tertiary referral centre. Ocul Immunol Inflamm. 2023;31(5):921–926. doi:10.1080/09273948.2022.2067067.
  • Mercuri SR, Moliterni E, Cerullo A, et al. Syphilis: a mini review of the history, epidemiology and focus on microbiota. New Microbiol. 2022;45(1):28–34.
  • Gozzi F, Gentile P, De Simone L, et al. Viral anterior uveitis. Saudi J Ophthalmol. 2022;36(4):356–364. doi:10.4103/sjopt.sjopt_80_22.
  • Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of ‘sunset glow fundus’ in initial-onset acute uveitis associated with Vogt–Koyanagi–Harada disease. Acta Ophthalmol. 2017;95(1):85–90. doi:10.1111/aos.13189.
  • Kaza H, Tyagi M, Agarwal K, et al. Vogt Koyanagi Harada disease in paediatric age group: clinical characteristics, remission, recurrences and complications in Asian Indian population. Semin Ophthalmol. 2022;37(2):187–192. doi:10.1080/08820538.2021.1948067.
  • Du L, Kijlstra A, Yang P. Vogt-Koyanagi-Harada disease: novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res. 2016;52:84–111. doi:10.1016/j.preteyeres.2016.02.002.
  • Bolletta E, Mastrofilippo V, Invernizzi A, et al. Clinical relevance of subcentimetric lymph node biopsy in the diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm. 2022;30(3):717–720. doi:10.1080/09273948.2020.1817503.
  • Casselman P, Cassiman C, Casteels I, Schauwvlieghe PP. Insights into multiple sclerosis-associated uveitis: a scoping review. Acta Ophthalmol. 2021;99(6):592–603. doi:10.1111/aos.14697.
  • Paroli MP, Spinucci G, Liverani M, Monte R, Pezzi PP. Uveitis in childhood: an Italian clinical and epidemiological study. Ocul Immunol Inflamm. 2009;17(4):238–242. doi:10.1080/09273940802702561.
  • Siak J, Kumaradas M, Chee SP. The pattern of uveitis in Sri Lanka. Ocul Immunol Inflamm. 2017;25(1):S63–S68. doi:10.1080/09273948.2017.1313991.
  • Abdelwareth Mohammed A, Soliman MM, Osman AA, El-Zanaty RT. Patterns of uveitis in Egypt. Ocul Immunol Inflamm. 2021;29(5):1007–1016. doi:10.1080/09273948.2020.1714060.
  • Abd El Latif E, Ammar H. Uveitis Referral pattern in upper and lower Egypt. Ocul Immunol Inflamm. 2019;27(6):875–882. doi:10.1080/09273948.2017.1410183.
  • Rautenbach W, Steffen J, Smit D, Lecuona K, Esterhuizen T. Patterns of uveitis at two university-based referral centres in Cape Town, South Africa. Ocul Immunol Inflamm. 2019;27(6):868–874. doi:10.1080/09273948.2017.1391954.
  • Solomon L, Tsegaw A. Pattern of uveitis at a tertiary eye care and training center, North-West Ethiopia. Ocul Immunol Inflamm. 2022;30(7–8):1848–1852. doi:10.1080/09273948.2021.1964030.
  • Jones NP, Anderton LC, Cheong FM, et al. Corticosteroid-induced osteoporosis in patients with uveitis. Eye. 2002;16(5):587–593. doi:10.1038/sj.eye.6700163.
  • Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2012;90(8):603–608. doi:10.1111/j.1755-3768.2012.02498.x.
  • Dick AD, Rosenbaum JT, Al-Dhibi HA, et al. Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals of Care for UveitiS (FOCUS) initiative. Ophthalmology. 2018;125(5):757–773. doi:10.1016/j.ophtha.2017.11.017.
  • Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis. 2018;77(6):808–818. doi:10.1136/annrheumdis-2018-213225.
  • Takase H, Acharya NR, Babu K, et al. Recommendations for the management of ocular sarcoidosis from the international workshop on ocular sarcoidosis. Br J Ophthalmol. 2021;105(11):1515–1519. doi:10.1136/bjophthalmol-2020-317354.
  • Zhao C, Zhang M, Zhao C. Immunosuppressive treatment of non-infectious uveitis: history and Current choices. Chinese Med Sci J. 2017;32(1):48–61. doi:10.24920/J1001-9242.2007.007.
  • Bolletta E, Macchioni P, Citriniti G, et al. Clinical features and prevalence of spondyloarthritis in a cohort of Italian patients presenting with acute nongranulomatous anterior uveitis. J Immunol Res. 2022;2022:1–9. doi:10.1155/2022/6632081.
  • Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376(17):1637–1646. doi:10.1056/nejmoa1614160.
  • Lin P, Suhler EB, Rosenbaum JT. The future of uveitis treatment. Ophthalmology. 2014;121(1):365–376. doi:10.1016/j.ophtha.2013.08.029.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.